康惠制药：证券简称变更为“康惠股份”

Core Viewpoint - The company will change its stock abbreviation from "康惠制药" to "康惠股份" effective September 29, 2025, while the stock code "603139" remains unchanged. This change aligns with the company's long-term development strategy and aims to enhance market understanding of its positioning, but it will not significantly impact current operational performance [1]. Group 1 - The abbreviation change is part of the company's long-term development plan [1] - The change is expected to help the market better understand the company's development positioning [1] - The change complies with relevant laws, regulations, and the company's articles of association [1]